Enrolling by invitationNCT07070284
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pneumonia (sCAP) in Elderly Patients"
Studying Syringocystadenoma papilliferum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Joan Sabater Riera
- Principal Investigator
- Jordi Rello, phD, MDEuropean Study Group Infections in the Elderly. ESCMID
- Enrollment
- 500 target
- Eligibility
- 65 years · All sexes
- Timeline
- 2025 – 2025
Study locations (18)
- University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, City of Zagreb, Croatia
- Thibaut Fraisse, Alès, France
- Centre Hospitalier Intercommunal Hôpitaux du Pays du Mont-Blanc - Site de Chamonix, Chamonix, France
- Centre hospitalier Alpes Léman, Contamine-sur-Arve, France
- Centre Hospitalier de Melun, Melun, France
- Hôpital Bichat - Claude-Bernard, Paris, France
- Evangelismos General Hospital, Athens, Greece
- Azienda Ospedaliero-Universitaria di Modena, Modena, Emilia-Romagna, Italy
- Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Lazio, Italy
- ASST del Garda - Ospedale Civile "La Memoria" di Gavardo, Gavardo, Lombardy, Italy
- ARNAS Civico-Di Cristina-Benfratelli Hospital - Infectious Diseases Unit, Palermo, Sicily, Italy
- Azienda Ospedaliero-Universitaria Pisana, Pisa, Tuscany, Italy
- Centro Hospitalar Universitário de São João (CHUSJ), Porto, Portugal
- Hospital Universitario Virgen del Rocío, Seville, Andalusia, Spain
- Bellvitge Universitary Hospital, L'Hospitalet de Llobregat, Barcelona, Spain
- +3 more locations on ClinicalTrials.gov
Collaborators
European Society of Clinical Microbiology and Infectious Diseases · Hospital Universitari de Bellvitge
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07070284 on ClinicalTrials.govOther trials for Syringocystadenoma papilliferum
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06877936Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag)Ramsay Générale de Santé
- RECRUITINGPHASE3NCT05722938Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)Biotest